trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Song YF et al. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma. 2006 J. Clin. Pathol. pmid:16489177
Rokhlin OW et al. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. 2006 Mol. Cancer Res. pmid:16513842
Endo T et al. Activities of maturation-promoting factor (MPF) and mitogen-activated protein kinase (MAPK) are not required for the global histone deacetylation observed after germinal vesicle breakdown (GVBD) in porcine oocytes. 2006 Reproduction pmid:16514187
Sah NK et al. Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells. 2006 Int. J. Radiat. Oncol. Biol. Phys. pmid:17011457
Kumar KS et al. Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. 2006 Oncol. Rep. pmid:17016591
Alao JP et al. Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells. 2006 Mol. Cancer pmid:17018141
Zhao LY et al. An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis. 2006 Cancer Res. pmid:17018599
Mogal A and Abdulkadir SA Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes. 2006 Mol. Cell. Probes pmid:16326072
Gan Y et al. Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. 2006 Biochem. Biophys. Res. Commun. pmid:16338217
Nishiyama A et al. Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin. 2006 Mol. Biol. Cell pmid:16339075
Solomon JM et al. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. 2006 Mol. Cell. Biol. pmid:16354677
Kishigami S et al. Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. 2006 Biochem. Biophys. Res. Commun. pmid:16356478
Baradari V et al. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. 2006 Endocr. Relat. Cancer pmid:17158768
Taghiyev AF et al. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. 2006 Cancer Biol. Ther. pmid:17110788
Hishikawa K and Fujita T [Basic research for renal regeneration]. 2006 Nippon Rinsho pmid:16895225
Meisel A et al. Inhibition of histone deacetylation protects wild-type but not gelsolin-deficient neurons from oxygen/glucose deprivation. 2006 J. Neurochem. pmid:16895577
Son YO et al. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata. 2006 J. Cell. Biochem. pmid:16817225
Lau QC et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. 2006 Cancer Res. pmid:16818622
Peng C et al. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. 2006 J. Cell. Biochem. pmid:16265664
Foltz G et al. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. 2006 Cancer Res. pmid:16818640
Mori T et al. Estrogen receptor-alpha methylation predicts melanoma progression. 2006 Cancer Res. pmid:16818643
Sato K et al. Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatment. 2006 Int. J. Oncol. pmid:16820886
Tsuji H et al. Dynamic and reversible changes in histone H3-Lys4 methylation and H3 acetylation occurring at submergence-inducible genes in rice. 2006 Plant Cell Physiol. pmid:16774928
Ibanez de Caceres I et al. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. 2006 Cancer Res. pmid:16707423
Imre G et al. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation. 2006 Cancer Res. pmid:16707469
Jaalouk DE et al. Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors. 2006 Virol. J. pmid:16603064
Lu Z et al. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. 2006 Oncogene pmid:16158053
Hwang DY and Ismail-Beigi F Control of Glut1 promoter activity under basal conditions and in response to hyperosmolarity: role of Sp1. 2006 Am. J. Physiol., Cell Physiol. pmid:16162661
Leng Y and Chuang DM Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. 2006 J. Neurosci. pmid:16837598
Aung HT et al. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. 2006 FASEB J. pmid:16816106
Banwell CM et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. 2006 Clin. Cancer Res. pmid:16609009
Ryu JK et al. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines. 2006 Cancer Lett. pmid:16009488
Zaveri NT et al. Regulation of the prepronociceptin gene and its effect on neuronal differentiation. 2006 Gene pmid:16935438
Dokras A et al. Epigenetic regulation of maspin expression in the human placenta. 2006 Mol. Hum. Reprod. pmid:16936308
Yamamura K et al. Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis. 2006 Br. J. Haematol. pmid:16939493
Das PM et al. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. 2006 Mol. Cancer pmid:16848908
Puppin C et al. HEX expression and localization in normal mammary gland and breast carcinoma. 2006 BMC Cancer pmid:16854221
Dannenberg LO and Edenberg HJ Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. 2006 BMC Genomics pmid:16854234
Bell CW et al. The extracellular release of HMGB1 during apoptotic cell death. 2006 Am. J. Physiol., Cell Physiol. pmid:16855214
Cecconi D et al. Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. 2005 Nov-Dec J. Proteome Res. pmid:16335935
Garcia BA et al. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. 2005 Nov-Dec J. Proteome Res. pmid:16335948
Tai HH et al. Dynamic histone acetylation of late embryonic genes during seed germination. 2005 Plant Mol. Biol. pmid:16307366
Kook SH et al. Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis. 2005 J. Biochem. Mol. Biol. pmid:16336792
Li XX et al. Function of c-Fos-like and c-Jun-like proteins on trichostatin A-induced G2/M arrest in Physarum polycephalum. 2005 Acta Biochim. Biophys. Sin. (Shanghai) pmid:16270156
Francia G et al. Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents. 2005 Mol. Cancer Ther. pmid:16227397
Chou SD et al. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells. 2005 Int. Immunol. pmid:16210330
Bai Y et al. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. 2005 J. Immunol. pmid:16210620
Chen G et al. [Enhancive effect of histone deacetylase inhibitor trichostatin a on transfection efficiency of adenovirus in ovarian carcinoma cell line A2780]. 2005 Ai Zheng pmid:16219132
Kasper LH et al. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. 2005 EMBO J. pmid:16237459
Columbaro M et al. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. 2005 Cell. Mol. Life Sci. pmid:16261260
Burlibaşa L and Gavrilă L Molecular and ultrastructural studies of the sperm chromatin from Triturus cristatus. 2005 Zygote pmid:16261764
Marengo E et al. Use of Legendre moments for the fast comparison of two-dimensional polyacrylamide gel electrophoresis maps images. 2005 J Chromatogr A pmid:16301071
Di-Poï N et al. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. 2005 J. Biol. Chem. pmid:16166081
Spengler ML et al. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism. 2005 Cell. Signal. pmid:15494207
Valenzuela-Fernández A et al. Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. 2005 Mol. Biol. Cell pmid:16148047
Davis FJ et al. Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15388503
Curtin BF et al. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure. 2005 J. Cell. Biochem. pmid:16149071
Chen JS and Faller DV Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. 2005 J. Cell. Physiol. pmid:15389542
Medugno L et al. The Krüppel-like zinc-finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP-1 co-repressor protein. 2005 Gene pmid:16150558
Frønsdal K and Saatcioglu F Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. 2005 Prostate pmid:15389787
Johnson J et al. Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid. 2005 Cell. Mol. Biol. (Noisy-le-grand) pmid:16171558
Karagiannis TC et al. The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X. 2005 Cancer Biol. Ther. pmid:16082178
Xiong Y et al. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. 2005 Gynecol. Oncol. pmid:16024066
Xu CR et al. Histone acetylation affects expression of cellular patterning genes in the Arabidopsis root epidermis. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:16176989
Wu P et al. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. 2005 Biochem. Biophys. Res. Commun. pmid:16051188
Yaneva M et al. Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor. 2005 Nucleic Acids Res. pmid:16177181
Kang JE et al. Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1. 2005 Cell. Physiol. Biochem. pmid:16121030
Chen CS et al. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. 2005 J. Biol. Chem. pmid:16186112
Bradbury CA et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. 2005 Leukemia pmid:16121216
Gurvich N et al. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. 2005 FASEB J. pmid:15901671
Zhao Y et al. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. 2005 J. Exp. Biol. pmid:15695762
Hooven LA et al. Effects of suberoylanilide hydroxamic acid and trichostatin A on induction of cytochrome P450 enzymes and benzo[a]pyrene DNA adduct formation in human cells. 2005 Bioorg. Med. Chem. Lett. pmid:15713371
Chen B et al. Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors. 2005 Bioorg. Med. Chem. Lett. pmid:15713393
Duan H et al. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. 2005 Mol. Cell. Biol. pmid:15713621
Tong X et al. Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. 2005 J. Biol. Chem. pmid:15713675
Gan Y et al. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. 2005 J. Biol. Chem. pmid:15722551
Endo M et al. Novel gender-related regulation of CYP2C12 gene expression in rats. 2005 Mol. Endocrinol. pmid:15661834
Sengupta S et al. Tumor suppressor p53 represses transcription of RECQ4 helicase. 2005 Oncogene pmid:15674334
Kim MS et al. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). 2005 Exp. Cell Res. pmid:15878336
Rosenqvist N et al. Inhibition of chromatin condensation prevents transgene silencing in a neural progenitor cell line transplanted to the rat brain. 2005 Cell Transplant pmid:15881422
Gonçalves J et al. Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells. 2005 Clin. Chem. Lab. Med. pmid:15843208
Robbins AR et al. Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin. 2005 Cell Cycle pmid:15846093
Taghiyev AF et al. Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. 2005 Cancer Biol. Ther. pmid:15846101
Barki-Celli L et al. Differences in nuclear positioning of 1q12 pericentric heterochromatin in normal and tumor B lymphocytes with 1q rearrangements. 2005 Genes Chromosomes Cancer pmid:15846776
Law RD and Suttle JC Chromatin remodeling in plant cell culture: patterns of DNA methylation and histone H3 and H4 acetylation vary during growth of asynchronous potato cell suspensions. 2005 Plant Physiol. Biochem. pmid:15922608
Seo H et al. Rapid generation of specific antibodies by enhanced homologous recombination. 2005 Nat. Biotechnol. pmid:15924134
Song Y et al. [The mechanisms of p21WAF1/Cip-1 expression in MOLT-4 cell line induced by TSA]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15854272
Xu ZM et al. [Analysis of the methylation in the promoter of LRP15 gene and its expression]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15854274
Mai A et al. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. 2005 J. Med. Chem. pmid:15857140
Choi YH Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. 2005 Int. J. Oncol. pmid:16010430
Taddei A et al. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? 2005 EMBO Rep. pmid:15940285
Gray SG et al. Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. 2005 J. Biol. Chem. pmid:15927959
Bai J et al. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. 2005 Cancer Res. pmid:15781649
Rahmani M et al. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. 2005 Cancer Res. pmid:15781658
Frescas D et al. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. 2005 J. Biol. Chem. pmid:15788402
Kang J et al. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. 2005 Biochem. Pharmacol. pmid:15794941
Narayanan R et al. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. 2005 Mol. Cell. Biol. pmid:15798179
Koh SH et al. Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death. 2005 Biochem. Biophys. Res. Commun. pmid:15752760
Mori T et al. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. 2005 Cancer Res. pmid:15753377
Dowling M et al. Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. 2005 Cancer Biol. Ther. pmid:15753652